Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion

The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7)...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 9; no. 29; pp. 20721 - 20733
Main Authors Muscarella, Lucia Anna, Turchetti, Daniela, Fontana, Andrea, Baorda, Filomena, Palumbo, Orazio, la Torre, Annamaria, de Martino, Danilo, Franco, Renato, Losito, Nunzia Simona, Repaci, Andrea, Pagotto, Uberto, Cinque, Luigia, Copetti, Massimiliano, Chiofalo, Maria Grazia, Pezzullo, Luciano, Graziano, Paolo, Scillitani, Alfredo, Guarnieri, Vito
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 17.04.2018
Subjects
Online AccessGet full text
ISSN1949-2553
1949-2553
DOI10.18632/oncotarget.25067

Cover

Abstract The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a gene mutation, clinical/histological diagnosis, age at onset, Ca , PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a gene mutation. A novel genomic deletion of the first 10 exons of the gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.
AbstractList The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca2+, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca2+, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.
The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca 2+ levels may predict the presence of a CDC73 mutation. We searched for large deletions at the CDC73 locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a CDC73 gene mutation, clinical/histological diagnosis, age at onset, Ca 2+ , PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a CDC73 gene mutation. A novel genomic deletion of the first 10 exons of the CDC73 gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a CDC73 mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca 2+ levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, p < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca 2+ > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.
The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a gene mutation, clinical/histological diagnosis, age at onset, Ca , PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a gene mutation. A novel genomic deletion of the first 10 exons of the gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.
Author Repaci, Andrea
Cinque, Luigia
Chiofalo, Maria Grazia
Turchetti, Daniela
Pezzullo, Luciano
Franco, Renato
Graziano, Paolo
Fontana, Andrea
Palumbo, Orazio
de Martino, Danilo
Copetti, Massimiliano
Muscarella, Lucia Anna
Baorda, Filomena
la Torre, Annamaria
Guarnieri, Vito
Pagotto, Uberto
Scillitani, Alfredo
Losito, Nunzia Simona
Author_xml – sequence: 1
  givenname: Lucia Anna
  surname: Muscarella
  fullname: Muscarella, Lucia Anna
  organization: Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 2
  givenname: Daniela
  surname: Turchetti
  fullname: Turchetti, Daniela
  organization: Medical Genetics, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy
– sequence: 3
  givenname: Andrea
  surname: Fontana
  fullname: Fontana, Andrea
  organization: Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 4
  givenname: Filomena
  surname: Baorda
  fullname: Baorda, Filomena
  organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 5
  givenname: Orazio
  surname: Palumbo
  fullname: Palumbo, Orazio
  organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 6
  givenname: Annamaria
  surname: la Torre
  fullname: la Torre, Annamaria
  organization: Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy, ISBReMIT, Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 7
  givenname: Danilo
  surname: de Martino
  fullname: de Martino, Danilo
  organization: Thoracic Surgery, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 8
  givenname: Renato
  surname: Franco
  fullname: Franco, Renato
  organization: Pathology , Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy
– sequence: 9
  givenname: Nunzia Simona
  surname: Losito
  fullname: Losito, Nunzia Simona
  organization: Pathology , Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy
– sequence: 10
  givenname: Andrea
  surname: Repaci
  fullname: Repaci, Andrea
  organization: Endocrinology, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy
– sequence: 11
  givenname: Uberto
  surname: Pagotto
  fullname: Pagotto, Uberto
  organization: Endocrinology, Sant’Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy
– sequence: 12
  givenname: Luigia
  surname: Cinque
  fullname: Cinque, Luigia
  organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 13
  givenname: Massimiliano
  surname: Copetti
  fullname: Copetti, Massimiliano
  organization: Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 14
  givenname: Maria Grazia
  surname: Chiofalo
  fullname: Chiofalo, Maria Grazia
  organization: Thyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy
– sequence: 15
  givenname: Luciano
  surname: Pezzullo
  fullname: Pezzullo, Luciano
  organization: Thyroid and Parathyroid Surgery Unit, Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli 80131, Italy
– sequence: 16
  givenname: Paolo
  surname: Graziano
  fullname: Graziano, Paolo
  organization: Pathology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 17
  givenname: Alfredo
  surname: Scillitani
  fullname: Scillitani, Alfredo
  organization: Endocrinology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
– sequence: 18
  givenname: Vito
  surname: Guarnieri
  fullname: Guarnieri, Vito
  organization: Medical Genetics, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29755684$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtvGyEQRpWrxnn8gF4ijr3YYdll2b1UqpynZKmX5IzYYdYmWYML2FL-fbDzqNNDucBovscw3zEZOe-QkO8FmxZNXfIL78AnHRaYplywWn4h46Kt2gkXohwdvI_IWYyPLB9RyYa338gRb6UQdVONSZjvFKjBAZP1jupE0xLp7HImS7pAh3TwsIlUO0Mj6gBL2vtA1wGNhWS3SFc6PGGI1Pd7Zu5EdIC7Wh_oJAt0wJg9TsnXXg8Rz97uE_JwfXU_u53Mf9_czX7NJ1AWlZyAMQ3rOPLOdKWWRncF66qmzv8AAUXNAWrRgOhE3xussdU9NwIMZx3Kqq_KE_LzVXe96VZoAF0KelDrYPPIz8prqz53nF2qhd8q0VZ5bWUW-PEmEPyfDcakVjYCDoN26DdRcVY2knHO2ww9P_T6MHlfdAYUrwAIPsaA_QekYGqfp_qbp9rnmTnyHw7YpHcx5XHt8B_mC_qHqmo
CitedBy_id crossref_primary_10_1002_jbmr_3650
crossref_primary_10_1155_2020_2080797
crossref_primary_10_3390_ijms22042016
crossref_primary_10_1007_s12020_021_02917_5
crossref_primary_10_2478_ebtj_2020_0008
crossref_primary_10_3390_endocrines4010018
crossref_primary_10_1155_2020_9298147
crossref_primary_10_3390_ijms25042301
crossref_primary_10_1016_j_beem_2018_11_002
crossref_primary_10_1111_ijlh_13569
crossref_primary_10_3390_cells10112920
Cites_doi 10.1097/MPH.0000000000000443
10.1210/jc.2012-2789
10.1111/cen.12461
10.1128/MCB.25.2.612-620.2005
10.1007/s12022-008-9050-2
10.1128/MCB.25.12.5052-5060.2005
10.1038/ng1048
10.1002/gcc.20911
10.1111/j.1365-2265.2011.04184.x
10.1210/jc.2014-1481
10.1002/humu.21188
10.1056/NEJMoa031237
10.1038/ncomms6433
ContentType Journal Article
Copyright Copyright: © 2018 Muscarella et al. 2018
Copyright_xml – notice: Copyright: © 2018 Muscarella et al. 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.18632/oncotarget.25067
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1949-2553
EndPage 20733
ExternalDocumentID PMC5945533
29755684
10_18632_oncotarget_25067
Genre Journal Article
GroupedDBID ---
53G
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
FRJ
GX1
HYE
KQ8
M48
OK1
PGMZT
RPM
NPM
7X8
5PM
ID FETCH-LOGICAL-c3147-cdd80b2e2bdb3a7dab10b486000c5c162cc658c5b5ffde6e9af2d5cd20be74f43
IEDL.DBID M48
ISSN 1949-2553
IngestDate Thu Aug 21 18:34:44 EDT 2025
Fri Jul 11 08:48:10 EDT 2025
Thu Apr 03 07:02:15 EDT 2025
Thu Apr 24 23:03:35 EDT 2025
Tue Jul 01 02:03:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 29
Keywords HPT-JT
large genomic deletion
early onset
CDC73
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3147-cdd80b2e2bdb3a7dab10b486000c5c162cc658c5b5ffde6e9af2d5cd20be74f43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/oncotarget.25067
PMID 29755684
PQID 2038702229
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5945533
proquest_miscellaneous_2038702229
pubmed_primary_29755684
crossref_primary_10_18632_oncotarget_25067
crossref_citationtrail_10_18632_oncotarget_25067
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-17
2018-Apr-17
20180417
PublicationDateYYYYMMDD 2018-04-17
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-17
  day: 17
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Oncotarget
PublicationTitleAlternate Oncotarget
PublicationYear 2018
Publisher Impact Journals LLC
Publisher_xml – name: Impact Journals LLC
References Corbetta (20) 2010; 35
Beckers (2) 2015; 2
23
Chanson (16) 2013; 98
Xing (18) 2014; 81
Cavaco (21) 2017; 6
24
Jones (8) 2002; 32
Diaz-Thomas (19) 2016; 38
Shaw (4) 1999; 3
Arnold (9) 2003; 349
Krek (10) 2005; 25
Thakker (13) 2010; 31
Mete (7) 2012; 4
Robledo (14) 2011; 50
Schalin-Jäntti (17) 2014; 99
Thakker (1) 2017; 12
Delellis (3) 2008; 4
Benvenga (5) 2012; 3
Cavaco (15) 2012; 76
Väisänen (22) 2017; 7
Baldari (6) 2017; 1
Meyerson (11) 2005; 25
Yoo (12) 2014; 5
References_xml – volume: 38
  start-page: 32
  year: 2016
  ident: 19
  article-title: Parathyroid Cancer in the Pediatric Patient
  publication-title: Journal of Pediatric Hematology/Oncology
  doi: 10.1097/MPH.0000000000000443
– volume: 98
  start-page: E403
  year: 2013
  ident: 16
  article-title: Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2012-2789
– volume: 3
  start-page: 155
  year: 1999
  ident: 4
  article-title: Parathyroid cancer: biology and management
  publication-title: Surg Oncol
– volume: 81
  start-page: 222
  year: 2014
  ident: 18
  article-title: Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese
  publication-title: Clinical Endocrinology (Oxf)
  doi: 10.1111/cen.12461
– volume: 25
  start-page: 612
  year: 2005
  ident: 11
  article-title: The parafibromin tumor suppressor protein is part of a human Paf1 complex
  publication-title: Molecular and Cellular Biology
  doi: 10.1128/MCB.25.2.612-620.2005
– volume: 4
  start-page: 221
  year: 2008
  ident: 3
  article-title: Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma
  publication-title: Endocr Pathol
  doi: 10.1007/s12022-008-9050-2
– volume: 25
  start-page: 5052
  year: 2005
  ident: 10
  article-title: The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II
  publication-title: Molecular and Cellular Biology
  doi: 10.1128/MCB.25.12.5052-5060.2005
– volume: 12
  start-page: 1621
  year: 2017
  ident: 1
  article-title: Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma
  publication-title: Hum Mutat
– volume: 32
  start-page: 676
  year: 2002
  ident: 8
  article-title: HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
  publication-title: Nature Genetics
  doi: 10.1038/ng1048
– volume: 50
  start-page: 922
  year: 2011
  ident: 14
  article-title: Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20911
– volume: 35
  start-page: 411
  year: 2010
  ident: 20
  article-title: CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort
  publication-title: Cellular Oncology (Dordr)
– volume: 76
  start-page: 33
  year: 2012
  ident: 15
  article-title: Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism
  publication-title: Clinical Endocrinology (Oxf)
  doi: 10.1111/j.1365-2265.2011.04184.x
– volume: 2
  start-page: 169
  year: 2015
  ident: 2
  article-title: Parathyroid carcinoma: Challenges in diagnosis and treatment
  publication-title: Ann Endocrinol (Paris)
– volume: 99
  start-page: 3044
  year: 2014
  ident: 17
  article-title: CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2014-1481
– volume: 31
  start-page: 295
  year: 2010
  ident: 13
  article-title: Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors
  publication-title: Human Mutation
  doi: 10.1002/humu.21188
– volume: 1
  start-page: 19
  year: 2017
  ident: 6
  article-title: Association of parathyroid carcinoma and thyroid disorders: A clinical review
  publication-title: Endocrine
– volume: 3
  start-page: 367
  year: 2012
  ident: 5
  article-title: Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism
  publication-title: J Bone Miner Metab
– volume: 7
  start-page: 991
  year: 2017
  ident: 22
  article-title: A nationwide study on parathyroid carcinoma
  publication-title: Acta Oncologica
– volume: 349
  start-page: 1722
  year: 2003
  ident: 9
  article-title: Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMoa031237
– volume: 5
  start-page: 5433
  year: 2014
  ident: 12
  article-title: Cytoplasmic parafibromin/hCDC73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis
  publication-title: Nature Communications
  doi: 10.1038/ncomms6433
– volume: 6
  start-page: e92061
  year: 2017
  ident: 21
  article-title: Genomic profiling reveals mutational landscape in parathyroid carcinomas
  publication-title: JCI Insight
– ident: 24
– volume: 4
  start-page: 221
  year: 2012
  ident: 7
  article-title: Biomarkers of parathyroid carcinoma
  publication-title: Endocr Pathol
– ident: 23
SSID ssj0000547829
Score 2.2711632
Snippet The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels...
The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca2+...
The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the CDC73 gene: it has been suggested that early onset of the disease and high Ca...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 20721
SubjectTerms Research Paper
Title Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion
URI https://www.ncbi.nlm.nih.gov/pubmed/29755684
https://www.proquest.com/docview/2038702229
https://pubmed.ncbi.nlm.nih.gov/PMC5945533
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEF6c5NJLaUmaumnDBnIKyNFjV7s6lFLcOCbEPdXgm9gnLbiSI9vQ_vvOrGTXbkKgR6F9iG9mNd_s7M4QclmIxCouVeTB-Iatm6hg2kauMDZ13nsWbvFPvubjKbub8VmPbMpbdQAun3TtsJ7UtJkPfj38_gQL_iMueJln6XWNeQzCwekBWPRcHJAjMEw5-mKTju23qb4Z2MMixJlZEQGZzro455Oj7FuqR_Tz31OUO2Zp9Iq87Pgk_dwqwGvSc9Uxae5xAoo1bhB3qlYUeB4dfhmKjILGOAombL2kqrK0VXUK3JUuGoza4P-P_sRTO82S1j70XIRLSsbhs9oZByalc4cbbidkOrr5NhxHXXGFyGQJE5GxVsY6dam2OlPCKp3EGitSxbHhJslTY4CcGK6599blrlA-tRwEGGsnmGfZG3JY1ZV7S6jNpJPMmDS2milMuGMAfuYkl94rwfok3gBZmi7zOBbAmJfogSD25V_sy4B9n1xtuyzatBvPNb7YSKeExYERD1W5er0sUwzOo0tb9MlpK63tcHilmOcSvk7syXHbABNv77-pfnwPCbh5wUB3snf_85Fn5AVwLYmBqES8J4erZu0-AJ9Z6XNycDtLzoOu_gEWYvoX
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Large+deletion+at+the+CDC73+gene+locus+and+search+for+predictive+markers+of+the+presence+of+a+CDC73+genetic+lesion&rft.jtitle=Oncotarget&rft.au=Muscarella%2C+Lucia+Anna&rft.au=Turchetti%2C+Daniela&rft.au=Fontana%2C+Andrea&rft.au=Baorda%2C+Filomena&rft.date=2018-04-17&rft.issn=1949-2553&rft.eissn=1949-2553&rft.volume=9&rft.issue=29&rft.spage=20721&rft.epage=20733&rft_id=info:doi/10.18632%2Foncotarget.25067&rft.externalDBID=n%2Fa&rft.externalDocID=10_18632_oncotarget_25067
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon